SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-008447
Filing Date
2018-02-08
Accepted
2018-02-08 16:29:01
Documents
2
Period of Report
2018-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5630
2 POA DOCUMENT poa.txt EX-24.3_767318 3766
  Complete submission text file 0001209191-18-008447.txt   10871
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Issuer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SIERRA ONCOLOGY, INC. 885 W. GEORGIA ST., #2150 VANCOUVER A1 V6C 3E8
Business Address
Hassig Christian (Reporting) CIK: 0001730657 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37490 | Film No.: 18586117